Should You Bank Your Baby’s Stem Cells? What Indian Parents Need to Know

Cord blood banking sounds like a once-in-a-lifetime opportunity to “save your baby’s stem cells.” But is it something every parent should pay for?

When you’re expecting a baby, you’re suddenly faced with dozens of decisions you’ve probably never had to think about before.

One of them may be:

“Would you like to preserve your baby’s stem cells?”

Private cord blood banks often present this as a form of biological insurance — pay now, preserve your baby’s cord blood, and potentially use it years later if your child develops a serious illness.

It sounds reassuring. But what does the evidence actually say — and does it look different for a family in India than it does for a family reading US-based marketing material?

We asked parents in the IPF community what their doctors told them, and what they decided.

First, what exactly is being preserved?

The blood left in the umbilical cord and placenta after birth contains hematopoietic stem cells — cells that can produce different types of blood cells.

These cells are used in stem-cell transplants for conditions including certain blood cancers, blood disorders, immune deficiencies, and inherited metabolic disorders.

Cord blood can be:

• Stored privately — reserved for the baby or the family, for a fee.
• Directed for a specific family member — collected because there’s already a known medical need in the family.
• Donated, where infrastructure exists, for use by a matched patient elsewhere.

And these situations are very different — which matters a lot for what “banking” actually means in India.

So should every baby have their cord blood privately stored?

No major medical body recommends routine private cord blood banking for healthy newborns with no family history of a treatable condition. This is the consistent position of the American Academy of Pediatrics (AAP), the American College of Obstetricians and Gynecologists (ACOG), and — most relevant for Indian parents — the Indian Academy of Pediatrics (IAP) 2018 consensus statement and ICMR’s 2023 national guidelines.

Here’s the number that actually matters, and it’s worth using instead of the vague “2–3% chance” figure that circulates in parenting WhatsApp groups: ICMR’s guidelines state that the likelihood of a privately banked unit ever being used for a transplant is as low as 0.005–0.04% in the first 20 years of a child’s life. That’s the figure to anchor on, not an estimate from a forwarded message.

So the better question isn’t:

“Can stem cells be useful?” — they absolutely can be.

It’s:

“Is paying to store my baby’s own cord blood likely to benefit my family?”

For most healthy families with no known medical indication, the honest answer is: probably not.

The India-specific catch almost no one mentions

This is the part that gets lost when parents read US parenting content on this topic.

In the US, the standard advice is “donate to a public bank instead of paying a private one.” That advice does not translate directly to India.

As of ICMR’s 2023 national guidelines, India does not have dedicated public cord blood banks. The infrastructure that lets a Western family donate for free and potentially help a stranger simply isn’t widely available here yet. In practice, an Indian family’s real options are closer to:

1. Pay a private bank to store it for possible family use.
2. Ask if your hospital has any donation or research tie-in (uncommon, and worth asking about directly rather than assuming).
3. Let it go unbanked, as has always been standard.

This doesn’t change the core medical conclusion — routine private banking still isn’t recommended for healthy newborns — but it does mean the “just donate publicly instead” advice you’ll see in a lot of international articles isn’t actually an option for most families delivering in India today.

One important limitation: your baby’s own cord blood may not always be useful for them

If a child develops a genetic disorder, the cord blood collected at birth often carries the same genetic abnormality. Similarly, in certain cancers such as leukemia, the stored cord blood may contain cells associated with the disease.

That means a child’s own stored cord blood may not be appropriate for treating that same child. In those cases, cells from a matched donor would be needed instead — which is part of why the “it’s insurance for your child” framing oversimplifies things.

But there ARE situations where banking makes real sense

This is where the conversation needs nuance, and it’s the one exception every guideline agrees on: banking makes sense when there is already a family member with a condition that could potentially be treated with a cord-blood transplant — for example, an older sibling with certain blood, immune, or genetic disorders.

In that case, the newborn’s cord blood can be collected for directed, related use, and both ICMR and IAP explicitly support this.

Banking because of a known medical reason is a very different decision from banking “just in case.”

What did IPF moms say?

We asked the IPF community about their own experiences and what their doctors told them.

One mom shared:

“My gynac indirectly said it’s useless… there is a very very low chance of you needing it and it being in a condition to be used. We decided not to.”

Another parent said:

“My gynec told it’s just a money making scam… otherwise it’s a waste of money.”

And another raised a different concern entirely — the trade-off with delayed cord clamping:

“A full term baby benefits more from the blood than doing early cord clamping to get cord blood.”

These are parents’ experiences and opinions, not medical recommendations — but they raise exactly the right questions to bring to your own obstetrician.

What about delayed cord clamping?

This deserves its own conversation with your doctor.

Collecting cord blood can sometimes mean less blood is available if the cord is left unclamped for longer, as recommended for newborn health.

Cord blood collection should never come at the cost of delayed cord clamping or routine newborn care. ICMR’s guidelines are explicit on this point, and it’s flagged as a genuine ethical concern in their document: early clamping purely to collect more cord blood for banking is not acceptable practice. India’s own newborn care guidance (INAP) recommends delayed clamping of at least one minute after birth.

Ask your doctor directly:

“Will collecting cord blood change how you plan to manage cord clamping at my delivery?”

Private banking vs. no banking, in the Indian context

Public donation — the “best of both worlds” option often cited internationally — currently isn’t available to most families delivering in India, which is exactly why this decision looks different here than in the US-based articles most parents encounter.

What about all those “future use” claims?

This is where parents need to be especially careful.

You’ll see claims that stored stem cells could one day help with autism, cerebral palsy, diabetes, or other neurological conditions. There is ongoing research in these areas — but research is not the same as an established treatment, and using cord blood for these purposes outside a formal clinical trial isn’t currently permitted under Indian regulation.

ICMR is direct about this: private banks marketing cord blood as “biological insurance” against a long list of future diseases is not supported by available evidence, and their guidelines specifically flag misleading advertising — including celebrity-endorsed campaigns — as a known problem in this industry.

So when a company tells you:

“Your baby’s stem cells could be useful for many diseases in the future,”

the right follow-up question is:

“Which of those uses are actually approved and in use today, and which are still experimental?”

If you’re considering banking, ask these 7 questions

1. What conditions can these cells actually treat today?
2. How likely is it that my child’s own stored cells would be medically suitable for them?
3. Could my baby’s cells be unusable if they later develop a genetic condition or leukemia?
4. What happens if the collected sample doesn’t contain enough viable cells?
5. What are the total costs — collection, processing, and long-term storage?
6. What happens to the sample if the bank shuts down or the facility changes hands?
7. Will collecting the cord blood affect delayed cord clamping or routine newborn care?

And perhaps the most useful one of all:

“If you were advising me as a doctor rather than selling me a storage plan, would you recommend this for my family?”

FAQ

Is cord blood banking worth it in India? For most healthy families with no history of a condition treatable by stem-cell transplant, ICMR, IAP, AAP, and ACOG all agree it isn’t routinely recommended. It can be worth considering if a sibling or close relative already has a relevant condition.

Does India have public cord blood banks? Not currently, per ICMR’s 2023 guidelines. This is a key difference from the US and some other countries, where public donation is presented as the recommended alternative to private banking.

What’s the actual chance my child would ever use their own banked cord blood? ICMR cites a likelihood as low as 0.005–0.04% within the first 20 years of life — not the higher “2–3%” figure sometimes shared informally.

Will collecting cord blood interfere with delayed cord clamping? It shouldn’t. ICMR guidelines and India’s INAP newborn-care recommendations are both explicit that cord blood collection must never come at the cost of recommended cord-clamping practice. Ask your doctor how they plan to handle both.

Can a baby’s own cord blood treat their own leukemia or genetic disorder? Usually not. If the condition is genetic, the same abnormality is typically present in the stored cord blood too, so cells from a matched donor are generally needed instead.

The bottom line

Cord blood is genuinely valuable — its stem cells are already used in established treatments for specific conditions. But that doesn’t mean every healthy newborn needs private cord blood preservation.

For most Indian families without a known medical indication, the evidence doesn’t support paying for it as routine “biological insurance.” If your family has a child or close relative with a condition that a cord-blood transplant could treat, the calculation is genuinely different — and worth a direct conversation with a qualified specialist well before your due date.

The goal isn’t to scare parents into banking, or to shame parents who choose to. It’s to make the decision with evidence, not fear.

This article is for general information and isn’t a substitute for personalised advice from your obstetrician, paediatrician, or a transplant specialist.

Sources

ACOG Committee Opinion on Umbilical Cord Blood Banking · AAP, “Cord Blood Banking for Potential Future Transplantation,” Pediatrics (2017) · ICMR, Guidelines for Umbilical Cord Blood Banking (2023) · Indian Academy of Pediatrics, Consensus Statement on Umbilical Cord Blood Banking, Indian Pediatrics (2018)